Merck and Moderna announced a successful late-stage trial for a melanoma vaccine. NPR's Leila Fadel talks to Dr. Robert Vonderheide of Penn Medicine and the American Association for Cancer Research.
Copyright 2026 NPR
Leila Fadel is a host of Morning Edition, as well as NPR's morning news podcast Up First.